409 related articles for article (PubMed ID: 11881427)
1. [Clinical experience with icodextrin. Multicenter study].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
[TBL] [Abstract][Full Text] [Related]
2. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
3. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
[TBL] [Abstract][Full Text] [Related]
4. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
van Hoeck KJ; Rusthoven E; Vermeylen L; Vandesompel A; Marescau B; Lilien M; Schroder CH
Nephrol Dial Transplant; 2003 Jul; 18(7):1383-7. PubMed ID: 12808177
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.
Wolfson M; Piraino B; Hamburger RJ; Morton AR;
Am J Kidney Dis; 2002 Nov; 40(5):1055-65. PubMed ID: 12407652
[TBL] [Abstract][Full Text] [Related]
6. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
[TBL] [Abstract][Full Text] [Related]
8. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
9. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
10. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
Mistry CD; Gokal R; Peers E
Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
[TBL] [Abstract][Full Text] [Related]
11. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
[TBL] [Abstract][Full Text] [Related]
12. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
13. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
[TBL] [Abstract][Full Text] [Related]
14. [Effect of using icodextrin as a starting therapy for peritoneal permeability].
Fernández-Reyes MJ; Bajo MA; del Peso G; Olea T; Sánchez-Villanueva RL; González E; Heras M; Sánchez R; Selgas R
Nefrologia; 2009; 29(2):130-5. PubMed ID: 19396318
[TBL] [Abstract][Full Text] [Related]
15. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
16. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
Gokal R; Mistry CD; Peers EM
Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
[TBL] [Abstract][Full Text] [Related]
17. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
[TBL] [Abstract][Full Text] [Related]
18. Allergic reactions to icodextrin in patients with renal failure.
Divino Fiho JC
Lancet; 2000 Apr; 355(9212):1364-5. PubMed ID: 10776767
[No Abstract] [Full Text] [Related]
19. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient.
Lee SH; Park HC; Sim SR; Chung SJ; Kim KJ; Park WI; Hong SW; Ha SK
J Nephrol; 2006; 19(5):673-6. PubMed ID: 17136700
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
